(2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide

C19H20ClN11O4 — CID 164562366

IUPAC(2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide
SMILES[2H]C([2H])([2H])NC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4nnn(C)n4)nc(-c4cncc(Cl)c4)nc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C19H20ClN11O4/c1-21-18(34)14-12(32)13(33)19(35-14)31-7-24-11-16(23-6-10-27-29-30(2)28-10)25-15(26-17(11)31)8-3-9(20)5-22-4-8/h3-5,7,12-14,19,32-33H,6H2,1-2H3,(H,21,34)(H,23,25,26)/t12-,13+,14-,19+/m0/s1/i1D3
InChIKeyYMWTUYMFVOLYJX-LKDOHDCYSA-N
MW504.91 g/mol
LogP-0.96
Rot. Bonds7

About (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide

(2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide (PubChem CID 164562366) has the molecular formula C19H20ClN11O4 and a molecular weight of 504.91 g/mol. Its IUPAC name is (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide.

Molecular Properties

Compound Name(2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide
PubChem CID164562366
Molecular FormulaC19H20ClN11O4
Molecular Weight504.91 g/mol
Exact Mass504.16
IUPAC Name(2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide
SMILES[2H]C([2H])([2H])NC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4nnn(C)n4)nc(-c4cncc(Cl)c4)nc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C19H20ClN11O4/c1-21-18(34)14-12(32)13(33)19(35-14)31-7-24-11-16(23-6-10-27-29-30(2)28-10)25-15(26-17(11)31)8-3-9(20)5-22-4-8/h3-5,7,12-14,19,32-33H,6H2,1-2H3,(H,21,34)(H,23,25,26)/t12-,13+,14-,19+/m0/s1/i1D3
InChIKeyYMWTUYMFVOLYJX-LKDOHDCYSA-N
XLogP-0.96
TPSA190.91 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500504.91
LogP ≤ 5-0.96
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Analyze (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide?
The IUPAC name of (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide (CID 164562366) is (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide.
What is the SMILES notation for (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide?
The canonical SMILES for (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide is [2H]C([2H])([2H])NC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4nnn(C)n4)nc(-c4cncc(Cl)c4)nc32)[C@H](O)[C@@H]1O.
What is the InChIKey of (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide?
The InChIKey is YMWTUYMFVOLYJX-LKDOHDCYSA-N. The full InChI is InChI=1S/C19H20ClN11O4/c1-21-18(34)14-12(32)13(33)19(35-14)31-7-24-11-16(23-6-10-27-29-30(2)28-10)25-15(26-17(11)31)8-3-9(20)5-22-4-8/h3-5,7,12-14,19,32-33H,6H2,1-2H3,(H,21,34)(H,23,25,26)/t12-,13+,14-,19+/m0/s1/i1D3.
What are the key properties of (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide?
(2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide has a molecular weight of 504.91 g/mol, XLogP of -0.96, 7 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3S,4R,5R)-5-[2-(5-chloro-3-pyridinyl)-6-[(2-methyltetrazol-5-yl)methylamino]purin-9-yl]-3,4-dihydroxy-N-(trideuteriomethyl)oxolane-2-carboxamide is sourced from PubChem (CID 164562366), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).